The Vascular Endothelial Growth Factor (VEGF) Inhibitor Market is expected to reach at a CAGR of 73% during the forecast period 2022-2028. Vascular endothelial growth factor (VEGF) is an angiogenic factor responsible for the formation of blood vessels from pre-existing blood vessels or vascular endothelial cells. This growth factor induces tumor angiogenesis and thus plays […]